Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY 4.0Cureus

Cervical Cancer Screening: Analyzing Recent Guideline Changes Against Current Trends of Human Papillomavirus (HPV) Risk Factors

  • Susan E Garber1
  • Leselle Pierre-Romain1
  1. 1Public Health: Preventive Medicine, St. George's University School of Graduate Studies, True Blue, GRD
Read full textPDFDOICite

Abstract

Cervical cancer screening is an important aspect of public health and preventive medicine and contributes to reducing cervical cancer-related deaths. Cervical cancer screening guidelines have changed over time, shifting toward less frequent screening recommendations and an increased age of screening onset. These changes have been influenced by advances in screening technology, cost-effectiveness considerations, and the widespread implementation of Human papillomavirus (HPV) vaccination. Epidemiologic trends demonstrate increasing HPV-related risk factors, declining screening adherence, and barriers related to knowledge, access, and patient-provider communication. This narrative review examines cervical cancer screening guideline changes in relation to current epidemiologic trends in HPV risk factors. Existing literature was reviewed to evaluate changes in screening recommendations, patterns of screening participation and adherence, shifts in HPV-related risk behaviors, and patient-provider communication barriers influencing screening uptake. Although updated screening guidelines are supported by technological advancements and cost-effectiveness considerations, increasing trends in HPV risk factors and reduced screening adherence may limit the effectiveness of less frequent screening strategies. This narrative review analyzes cervical cancer screening guideline changes in relation to current epidemiologic trends in HPV risk factors, an important consideration when evaluating screening policy decisions.

Related

  1. 2022 WHO estimates for overall and human papillomavirus test-based cervical cancer screening coverage worldwide: a review and synthetic analysis
    Beatriz Serrano, Esther Roura, Laia Alemany +10
    The Lancet Global HealthPeer-reviewedCC BY-NC-ND 3.0-IGOEpidemiology & public healthCrossref
  2. Healthcare professionals' communication practices and preparedness in organised human papillomavirus-based cervical Cancer screening: A cross-sectional study in Central Portugal.
    Rita Sousa, José Alberto Fonseca-Moutinho, Fábio Gomes +3
    Preventive medicine reportsPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  3. Divergent Human Papillomavirus Genotype Spectra in Three Indigenous Communities of Venezuela: Implications for Vaccine Choice and Cervical Screening.
    María Fátima Garcés, Jefferson Guzmán Silva, Daniel Aranguren +6
    Diseases (Basel, Switzerland)Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  4. Follow-up after fertility-sparing surgery for cervical cancer: should human papillomavirus testing be used routinely? A narrative review
    David Viveros-Carreño, Isabel Beshar, Nathalia Mora-Soto +5
    International journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyPeer-reviewedLicence not statedFull textObstetrics, gynaecology & paediatricsPMC
  5. Cervical cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
    D. Lorusso, D. Cibula, I. Colombo +13
    ESMO OpenPeer-reviewedCC BY-NC-ND 4.0Full text1 citedObstetrics, gynaecology & paediatricsPMC

Cite

BibTeXRIS
BibTeX
@article{garber2026cervical,
  title = {{Cervical Cancer Screening: Analyzing Recent Guideline Changes Against Current Trends of Human Papillomavirus (HPV) Risk Factors}},
  author = {Susan E Garber and Leselle Pierre-Romain},
  journal = {Cureus},
  year = {2026},
  month = oct,
  doi = {10.7759/cureus.117745},
  url = {https://doi.org/10.7759/cureus.117745},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Cervical Cancer Screening: Analyzing Recent Guideline Changes Against Current Trends of Human Papillomavirus (HPV) Risk Factors
AU  - Susan E Garber
AU  - Leselle Pierre-Romain
PY  - 2026
DA  - 2026/10/10
JO  - Cureus
DO  - 10.7759/cureus.117745
UR  - https://doi.org/10.7759/cureus.117745
AB  - Cervical cancer screening is an important aspect of public health and preventive medicine and contributes to reducing cervical cancer-related deaths. Cervical cancer screening guidelines have changed over time, shifting toward less frequent screening recommendations and an increased age of screening onset. These changes have been influenced by advances in screening technology, cost-effectiveness considerations, and the widespread implementation of Human papillomavirus (HPV) vaccination. Epidemiologic trends demonstrate increasing HPV-related risk factors, declining screening adherence, and barriers related to knowledge, access, and patient-provider communication. This narrative review examines cervical cancer screening guideline changes in relation to current epidemiologic trends in HPV risk factors. Existing literature was reviewed to evaluate changes in screening recommendations, patterns of screening participation and adherence, shifts in HPV-related risk behaviors, and patient-provider communication barriers influencing screening uptake. Although updated screening guidelines are supported by technological advancements and cost-effectiveness considerations, increasing trends in HPV risk factors and reduced screening adherence may limit the effectiveness of less frequent screening strategies. This narrative review analyzes cervical cancer screening guideline changes in relation to current epidemiologic trends in HPV risk factors, an important consideration when evaluating screening policy decisions.
SN  - 2168-8184
ER  -